Outcomes associated with in-center nocturnal hemodialysis from a large multicenter program

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 2, 2010, Pages 220-226

  Lacson Jr , Eduardo ^a   Wang, Weiling ^a   Lester, Keith ^a   Ofsthun, Norma ^a   Lazarus, J Michael ^a   Hakim, Raymond M ^a  

^a Fresenius Medical Care North America ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HEMOGLOBIN; PHOSPHORUS;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CASE MIX; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSATE; FEMALE; FLOW RATE; GEOGRAPHIC DISTRIBUTION; HAZARD RATIO; HEALTH CARE FACILITY; HEMODIALYSIS; HOSPITAL CHARGE; HOSPITALIZATION; HUMAN; IN CENTER NOCTURNAL HEMODIALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; SURVIVAL RATE; WEIGHT GAIN;

ADULT; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; NORTH AMERICA; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROGRAM EVALUATION; PROPORTIONAL HAZARDS MODELS; QUALITY INDICATORS, HEALTH CARE; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77749328871     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06070809     Document Type: Article

References (22)

1. US Renal Data System: USRDS Annual Data Report: Atlas of Chronic Kidney and End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008
2. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
3. Lacson E Jr, Diaz-Buxo JA: Daily and nocturnal hemodialysis: How do they stack up? Am J Kidney Dis 38: 225-239, 2001
4. Suri RS, Garg AX, Chertow GM, Levin NW, Rocco MV, Greene T, Beck GJ, Gassman JJ, Eggers PW, Star RA, Ornt DB, Kliger AS: Frequent Hemodialysis Network (FHN) randomized trials: Study design. Kidney Int 71: 349-359, 2007
5. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney Int 69: 1222-1228, 2006
6. Marshall MR, Byrne BG, Kerr PG, McDonald SP: Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients. Kidney Int 69: 1229-1236, 2006
7. Charra B, Chazot C, Jean G, Hurot JM, Vanel T, Terrat JC, VoVan C: Long 3 x 8 hr dialysis: A three-decade summary. J Nephrol 16[Suppl 7]: S64-S69, 2003
8. Shaldon S: First use of nocturnal hemodialysis. Kidney Int 76: 230, 2009
9. Deziel C, Bichet D, Cartier P, Charbonneau R, Daigneault B, Madore F, Querin S: In-center long duration (8h) overnight hemodialysis (LDHD): Sept. 95-May 1999 [Abstract]. J Am Soc Nephrol 10: 190A, 1999
10. Troidle L, Hotchkiss M, Finkelstein F: A thrice weekly in-center nocturnal hemodialysis program. Adv Chronic Kidney Dis 14: 244-248, 2007
11. Bugeja A, Dacouris N, Thomas A, Marticorena R, Mc-Farlane P, Donnelly S, Goldstein M: In-center nocturnal hemodialysis: Another option in the management of chronic kidney disease. Clin J Am Soc Nephrol 4: 778-783, 2009
12. Powell JR, Oluwaseun O, Woo YM, Padmanabhan N, Narasinghan E, Latta C, Tortolano J, Jardine AG, Geddes CC: Ten years experience of in-center thrice weekly long overnight hemodialysis. Clin J Am Soc Nephrol 4: 1097-1101, 2009
13. Lacson E Jr, Wang W, Hakim RM, Teng M, Lazarus JM: Associates of mortality and hospitalization in hemodialysis: Potentially actionable laboratory variables and vascular access. Am J Kidney Dis 53: 79-90, 2009
14. Greene T, Beck GJ, Gassman JJ, Gotch FA, Kusek JW, Levey AS, Levin NW, Schulman G, Eknoyan G: Design and statistical issues of the hemodialysis (HEMO) study. Control Clin Trials 21: 502-525, 2000
15. Lacson E Jr, Ikizler TA, Lazarus JM, Teng M, Hakim RM: Potential impact of nutritional intervention on end-stage renal disease hospitalization, death, and treatment costs. J Ren Nutr 17: 363-371, 2007
16. Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A: Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 53: 1399-1404, 1998
17. Saito A, Suzuki I, Chung TG, Okamoto T, Hotta T: Separation of an inhibitor of erythropoiesis in "middle molecules" from hemodialysate from patients with chronic renal failure. Clin Chem 32: 1938-1941, 1986
18. Ifudu O, Feldman J, Friedman EA: The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 334: 420-425, 1996
19. Pierratos A: Daily (quotidian) nocturnal home hemodialysis: Nine years later. Hemodial Int 8: 45-50, 2004
20. Ramkumar N, Beddhu S, Eggers P, Pappas LM, Cheung AK: Patient preferences for in-center intense hemodialysis. Hemodial Int 9: 281-295, 2005
21. Lockridge RS Jr, Spencer M, Craft V, Pipkin M, Campbell D, McPhatter L, Albert J, Anderson H, Jennings F, Barger T: Nocturnal home hemodialysis in North America. Adv Ren Replace Ther 8: 250-256, 2001
22. van Manen JG, van Dijk PC, Stel VS, Dekker FW, Cleries M, Conte F, Feest T, Kramar R, Leivestad T, Briggs JD, Stengel B, Jager KJ: Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant 22: 187-195, 2007